Log in to search using one of your social media accounts:

 

Study of Anthurium schlechtendalii Kunth Extract Effects on Nephroprotective or Renal Damage Remission Capacity

This study was aimed at investigating the nephroprotective potential of Anthurium schlechtendalii (A. schlechtendalii) Kunth root consumption as a traditional medicine for kidney disease in Mexico. Materials and Methods: Oral administration of adenine (0.75%) induced chronic kidney disease and solid and aqueous extract from plant root. These were tested at doses of 125 mg kg–1/day and 1.8 mg mL–1/day, respectively in the animal model used in 4 weeks experiment. Growth parameters, liquid consumption, 24 h urine volume, kidney weight, creatinine, creatinine clearance, blood urea nitrogen (BUN) and urine proteins were determined and also statistically recognized by variance analysis procedures (one-way ANOVA), with a post hoc Tukey multiple range test for comparison of means (p
Source: Research Journal of Medicinal Plant - Category: Complementary Medicine Source Type: research

Related Links:

FRIDAY, Feb. 23, 2018 -- Chronic kidney disease may affect brain function in children and teens, especially those on dialysis, researchers say. Results of their study review suggest academic assistance may be needed in specific areas, including...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Conclusions In this case-control, survey-based study, the prevalence of nephrolithiasis was 2 times higher in patients with CLD.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research
AbstractMany cardiovascular diseases present renin –angiotensin–aldosterone system (RAAS) hyperactivity as an important pathophysiological mechanism to be target in the therapeutic approaches. Moreover, arterial stiffness is currently considered as a new independent risk factor for cardiovascular disease in different clinical conditions, includi ng hypertension and chronic kidney disease. In fact, excessive stimulation of angiotensin type 1 (AT1) receptors, as well as mineralocorticoid receptors, results in cellular growth, oxidative stress and vascular inflammation, which may lead to arterial stiffness and acc...
Source: High Blood Pressure and Cardiovascular Prevention - Category: Cardiology Source Type: research
There is a large and growing burden of diabetes globally. In 2013, 382 million people had diabetes and this number has been projected to increase to 592 million by 2035 [1]. With increasing life expectancy and prevalence of type 2 diabetes, complications and deaths attributable to diabetes will also increase, especially if there is no concomitant improvement in the health system for its early management [1]. Chronic kidney disease (CKD) is a common complication in people with type 2 diabetes [2] and may in some cases progress to end-stage renal disease, which requires dialysis and/or kidney transplant which are associated ...
Source: Primary Care Diabetes - Category: Primary Care Authors: Tags: Original research Source Type: research
ConclusionOur results prompt another mechanism of anti-fibrotic renal protection of renalase, which may be partly associated with inhibiting oxidative stress. These data provided another theoretical basis that supplementation with exogenous renalase may be a promising strategy for slowing or halting the progression of CKD.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
Conclusion: CKD is frequent at PAH diagnosis and is independently associated with increased mortality. Right heart failure may induce renal hypoperfusion and congestion, and is associated with eGFR decrease.Am J Nephrol 2018;47:134 –143
Source: American Journal of Nephrology - Category: Neurology Source Type: research
Source: BMJ Comments - Category: General Medicine Source Type: forums
KDIGO released new guidelines on chronic kidney disease-mineral and bone disorder for nephrologists and primary care physicians, many of whom care for patients with chronic kidney disease themselves.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news
Authors: Li JX, Yu GQ, Zhuang YZ Abstract OBJECTIVE: To investigate the impact of serum FGF23 levels on blood pressure of patients with chronic kidney disease (CKD). PATIENTS AND METHODS: 128 patients with chronic kidney disease were selected from February 2013 to January 2016. Using CKD staging method, all the patients were divided into 1 to 5 stages according to the glomerular filtration rate. Enzyme-Linked ImmunoSorbent Assay (ELISA) was used to detect serum FGF23 levels of CKD patients and healthy control subjects. 24 h blood pressure monitoring method was used to monitor the mean arterial pressure of patie...
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Abstract BACKGROUND: Pulmonary arterial hypertension (PAH) may lead to right heart failure and subsequently alter glomerular filtration rates (GFR). Chronic kidney disease (CKD, GFR
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Tags: Am J Nephrol Source Type: research
More News: Chronic Kidney Disease | Complementary Medicine | Herbs | Mexico Health | Statistics | Study | Urology & Nephrology | Weight Loss